在COPD中DSbA-L的保护作用:通过AMPK激活缓解ER压力诱导的亡
Siqi Li1, Zhenyu Peng2, Qiong Huang1
1Department of Geriatric Respiratory and Critical Care Medicine, Xiangya Hospital, Central South University, Changsha 410008, China; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha 410008, China.
Environmental pollution (Barking, Essex : 1987)
|September 20, 2025
概括
双硫化键甲氧化还原酶类蛋白 (DsbA-L) 通过减少内质网膜 (ER) 应激和亡,保护免受慢性阻塞性肺病 (COPD) 的影响. 它的下调加速了COPD的进展,这表明DSbA-L是治疗目标.
科学领域:
- 肺部医学 肺部医学
- 细胞生物学 细胞生物学
- 分子医学是分子医学.
背景情况:
- 慢性阻塞性肺病 (COPD) 与亡和内细胞网膜 (ER) 压力有关.
- 在COPD病变发生过程中,二硫化键A氧化还原酶类蛋白 (DsbA-L) 的特定作用尚不清楚.
研究的目的:
- 研究DSbA-L在COPD病理生理学中的作用.
- 在COPD模型中探索DSbA-L影响ER压力和亡的潜在机制.
主要方法:
- 使用暴露于香烟烟雾的小鼠和用香烟烟雾提取物 (CSE) 处理的BEAS-2B细胞创建了COPD模型.
- 评估了DSbA-L表达,细胞亡标志物和ER压力标志物.
- 在DSbA-L淘汰赛小鼠和转基因BEAS-2B细胞 (淘汰赛/过度表达) 中检查了DSbA-L功能.
主要成果:
- 发现DsbA-L表达在COPD模型的呼吸道上皮质中受到下调.
- 通过PERK酸化,DSbA-L缺乏加剧了COPD的进展,增加了细胞亡和ER压力标志物.
- DsbA-L的过度表达减轻了CSE诱导的亡和ER压力,这种效应取决于腺单酸活性蛋白激酶 (AMPK) 信号传递.
结论:
- DsbA-L通过减弱ER压力诱导的亡,在COPD中起着保护作用.
- 保护机制涉及AMPK信号通路.
- DsbA-L代表了治疗COPD的潜在治疗目标.
相关概念视频
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
4.2K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
4.2K
01:26COPD: Management Using Bronchodilators and Corticosteroids
737
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
737
01:31Regulation of the Unfolded Protein Response
2.9K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.9K
01:20COPD: Pathogenesis and Clinical Features
1.8K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.8K
01:22Chronic Obstructive Pulmonary Disease
2.3K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.3K
01:29Chronic Obstructive Pulmonary Disease-V: Management
3.1K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.1K